Dose-response effect of L-theanine on psychomotor speed, sustained attention, and inhibitory control: a double-blind, placebo-controlled, crossover study

被引:2
|
作者
Dassanayake, Tharaka L. [1 ,2 ]
Wijesundara, Devasmitha [1 ]
Kahathuduwa, Chanaka N. [3 ,4 ]
Weerasinghe, Vajira S. [1 ]
机构
[1] Univ Peradeniya, Fac Med, Dept Physiol, Peradeniya 20400, Sri Lanka
[2] Univ Newcastle, Sch Psychol Sci, Callaghan, NSW, Australia
[3] Texas Tech Univ, Sch Med, Dept Psychiat, Hlth Sci Ctr, Lubbock, TX USA
[4] Texas Tech Univ, Hlth Sci Ctr, Dept Lab Sci & Primary Care, Lubbock, TX 79430 USA
关键词
Theanine; attention; cognitive functions; reaction time; sustained attention; inhibitory control; stop-signal task; placebo-controlled trial; UNIQUE AMINO-ACID; STOP-SIGNAL; GREEN TEA; CAFFEINE; COMBINATION; COGNITION; CONSUMPTION; TASK;
D O I
10.1080/1028415X.2022.2136884
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: L-theanine is a non-protein-forming amino acid found in tea. Previous research shows high doses (100-400 mg) of L-theanine enhances attention, mainly by reducing mind wandering and distracter processing. We hypothesized that these indirect mechanisms could significantly improve the performance of low-level attentional tasks, whereas the relative contribution could be less in complex attentional tasks that require active, higher-order processing of target stimuli. Methods: To test this hypothesis, we conducted a double-blind, placebo-controlled, counterbalanced, four-way crossover study in 32 healthy young adults, where we compared the effects of three doses of L-theanine (100, 200 and 400 mg) with a placebo (distilled water), administered before and 50 min after dosing, on three attentional tasks from the Cambridge Neuropsychological Test Automated Battery [viz. Reaction Time (RTI)-visuomotor speed, Rapid Visual Information Processing (RVP)-sustained attention, and Stop Signal Task (SST)-inhibitory control]. Results were analyzed in dose x time repeated measures ANOVA models, with subsequent pairwise comparisons. Results: Active doses significantly improved reaction times in the RTI (100-200 mg) and RVP (200-400 mg) tasks from baseline (p < 0.05), but once controlled for the change-from-baseline caused by placebo, only the RTI simple reaction times showed significant improvements, following 100 mg (Delta = 16.3 ms, p = 0.009) and 200 mg (Delta = 16.9 ms, p = 0.009) of L-theanine. Conclusions: Consistent with our hypothesis, these findings suggest that L-theanine significantly improves attention in simple visuomotor tasks, but not in more complex sustained attention tasks, or executive control tasks that require top-down inhibition of pre-active responses.
引用
收藏
页码:1138 / 1146
页数:9
相关论文
共 50 条
  • [41] TREATMENT OF ERECTILE FAILURE WITH PROSTAGLANDIN-E1 - A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY
    GODSCHALK, MF
    CHEN, JZ
    KATZ, PG
    MULLIGAN, T
    JOURNAL OF UROLOGY, 1994, 151 (06): : 1530 - 1532
  • [42] Fluoxetine and premature ejaculation: A double-blind, crossover, placebo-controlled study
    Haensel, SM
    Klem, TMAL
    Hop, WCJ
    Slob, AK
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (01) : 72 - 77
  • [43] CISAPRIDE IN THE POSTCHOLECYSTECTOMY SYNDROME - A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY
    BOUZO, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 47 (03): : 566 - 570
  • [44] A randomized, double-blind, placebo-controlled, dose-response efficacy and safety study of paliperidone palmitate in adults with schizophrenia
    Pandina, G.
    Lindenmayer, J. -P.
    Lull, J.
    Lim, P.
    Gopal, S.
    Herben, V.
    Kusumakar, V.
    Yuen, E.
    Palumbo, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 232 - 232
  • [45] Effect of crocetin on quality of sleep: A randomized, double-blind, placebo-controlled, crossover study
    Umigai, Naofumi
    Takeda, Ryuji
    Mori, Atsuko
    COMPLEMENTARY THERAPIES IN MEDICINE, 2018, 41 : 47 - 51
  • [46] Effect of Alpha-S1-Casein Tryptic Hydrolysate and L-Theanine on Poor Sleep Quality: A Double Blind, Randomized Placebo-Controlled Crossover Trial
    Thiagarajah, Kokila
    Chee, Huei Phing
    Sit, Nam Weng
    NUTRIENTS, 2022, 14 (03)
  • [47] SERTRALINE FOR SOCIAL PHOBIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED CROSSOVER STUDY
    KATZELNICK, DJ
    KOBAK, KA
    GREIST, JH
    JEFFERSON, JW
    MANTLE, JM
    SERLIN, RC
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (09): : 1368 - 1371
  • [48] Dose-Response of Paraxanthine on Cognitive Function: A Double Blind, Placebo Controlled, Crossover Trial
    Xing, Dante
    Yoo, Choongsung
    Gonzalez, Drew
    Jenkins, Victoria
    Nottingham, Kay
    Dickerson, Broderick
    Leonard, Megan
    Ko, Joungbo
    Faries, Mark
    Kephart, Wesley
    Purpura, Martin
    Jaeger, Ralf
    Wells, Shawn D.
    Sowinski, Ryan
    Rasmussen, Christopher J.
    Kreider, Richard B.
    NUTRIENTS, 2021, 13 (12)
  • [49] Phase 2, Double-blind, Placebo-controlled, Dose-Response Trial of Intravenous Adenosine for Perioperative Analgesia
    Habib, Ashraf S.
    Minkowitz, Harold
    Osborn, Timothy
    Ogunnaike, Babatunde
    Candiotti, Keith
    Viscusi, Eugene
    Gu, Jiezhun
    Creed, Mary R.
    Gan, Tong J.
    ANESTHESIOLOGY, 2008, 109 (06) : 1085 - 1091
  • [50] Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial
    Garber, AJ
    Duncan, TG
    Goodman, AM
    Mills, DJ
    Rohlf, JL
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (06): : 491 - 497